Search hospitals > Minnesota > Shakopee
Saint Francis Regional Medical Center
Claim this profileShakopee, Minnesota 55379
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
314 reported clinical trials
11 medical researchers
Summary
Saint Francis Regional Medical Center is a medical facility located in Shakopee, Minnesota. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Ovarian Cancer and other specialties. Saint Francis Regional Medical Center is involved with conducting 314 clinical trials across 437 conditions. There are 11 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
David M. KingPark Nicollet Clinic - Saint Louis Park8 years of reported clinical research
Expert in Lung Cancer
Expert in Breast Cancer
104 reported clinical trials
167 drugs studied
Daniel M. AndersonAbbott-Northwestern Hospital6 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
61 reported clinical trials
110 drugs studied
Yan JiRegions Hospital2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
32 reported clinical trials
78 drugs studied
Pamala A. PawloskiPark Nicollet Clinic - Saint Louis Park6 years of reported clinical research
Studies Cancer
Studies Relapse
14 reported clinical trials
19 drugs studied
Clinical Trials running at Saint Francis Regional Medical Center
Lung Cancer
Prostate Cancer
Bladder Cancer
Breast Cancer
Cancer
Colorectal Cancer
Kidney Cancer
Ovarian Cancer
Breast cancer
Pancreatic Cancer
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Francis Regional Medical Center?
Saint Francis Regional Medical Center is a medical facility located in Shakopee, Minnesota. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Ovarian Cancer and other specialties. Saint Francis Regional Medical Center is involved with conducting 314 clinical trials across 437 conditions. There are 11 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.
Where is Saint Francis Regional Medical Center located?
**Saint Francis Regional Medical Center**
Location: 1455 St. Francis Ave, Shakopee, MN 55379
Directions: From US-169 S, take the exit onto Marschall Rd S. Turn left onto St. Francis Ave. The hospital will be on your right.
Who should I call to ask about financial aid or insurance network?
**Saint Francis Regional Medical Center - Financial Assistance and Insurance Inquiries**
- **Eligibility and Enrollment Department:** For financial assistance applications, eligibility for government health insurance programs, and discounts based on the Federal Poverty Level, contact us at:
- **Address:** 3628 E. Imperial Highway, Suite #104, Lynwood, CA 90262
- **Phone:** 888-874-2585
- **Billing Department:** For billing concerns or questions about a specific bill, please call:
- **Phone:** 612.262.9000 or 800.859.5077
- **Website:** Visit the Allina Health website for more information.
- **Self-Pay and Assistance:** To inquire about self-pay options or qualifying for assistance, call 952.428.2569.
- **Account Information:** For financial brochures in English and Spanish, call 888-247-0125.
Financial assistance is available to those who qualify.
What insurance does Saint Francis Regional Medical Center accept?
Saint Francis Regional Medical Center accepts a variety of insurance plans, such as Saint Francis Health Plans, PacificSource Medicare Advantage, Premera PersonalCare, Regence Accountable Health Networks, Uniform Medical Plan Plus, and United Healthcare Charter. It also participates in individual and family plans available on MNsure for in-network coverage. Note that insurance plan acceptance may vary by facility within the Saint Francis Health System.
What awards or recognition has Saint Francis Regional Medical Center received?
Saint Francis Regional Medical Center, located in Shakopee, Minnesota, is distinguished by the Patient Safety Excellence Award™ and the Pulmonary Care Excellence Award™. It has also earned national recognition for its exceptional stroke care.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.